生物技术掀起的又一个浪潮冲击着澳大利亚。Peptide技术有限公司(悉尼,澳大利亚)是最近成立的,它是大批利用一些由Carlsberg生物技术有限公司(哥本哈根,丹麦)研究出的用于合成肽的酶方法的公司。该公司通过公开集资增加了840万美元。Peptide技术公司(Peptech)支付190多万美元得到了Carlsberg生物技术公司(Carbioteh)的技术使用权, 并获得Carlbiotech中30％的,Carbiotech及过来也从Peptecech中获得了43％的使用权。该 Another wave of rising biotechnology hit Australia. Peptide Technology Co., Ltd. (Sydney, Australia) was recently founded and it is a company that has made extensive use of some of the enzyme methods used to synthesize peptides developed by Carlsberg Biotech Co., Ltd. (Copenhagen, Denmark). The company added 8.4 million U.S. dollars through public funding. Peptide Technology (Peptech) paid for more than 1.9 million US dollars to obtain the right to use the technology of Carlsberg Biotech (Carbioteh), and obtained 30% of Carlbiotech, and Carbiotech also received 43% of the right to use it from Peptecech. The